| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 03/30/1993 | US5197882 Periodontal barrier and method for aiding periodontal tissue regeneration agents |
| 03/30/1993 | CA1315202C Oral sustained release acetaminophen formulation and process |
| 03/30/1993 | CA1315200C Sustained-release particulate preparation and process for preparing the same |
| 03/30/1993 | CA1315199C Confection product and method for making same |
| 03/30/1993 | CA1315198C Liposome continuous size reduction method and apparatus |
| 03/29/1993 | CA2079157A1 Pharmaceutical compositions |
| 03/27/1993 | CA2079042A1 Combination containing growth factors and polyelectrolytes |
| 03/26/1993 | CA2078899A1 Bioadhesive pharmaceutical carrier |
| 03/25/1993 | DE4131562A1 Arzneistofftraeger aus festen lipidteilchen-feste lipidnanosphaeren (sln) Arzneistofftraeger of solid lipid particles Tight lipidnanosphaeren (sln) |
| 03/24/1993 | EP0533518A1 Pharmaceutical composition for topical application containing dithranol and process for its preparation |
| 03/24/1993 | EP0533504A1 Dihydropyridine derivatives useful in antitumor therapy |
| 03/24/1993 | EP0533410A1 Method of administering dipalmitoyl/phosphatidylcholine dispersions |
| 03/24/1993 | EP0533297A1 Controlled-release pharmaceutical formulations |
| 03/24/1993 | EP0533281A1 The use of ranitidine bismuth citrate and one or more heliocobacte pylon-inhibiting antibiotics with manufacture of a medicament for treating gastrointestinal disorders |
| 03/24/1993 | EP0533103A1 Production of beta-form thiamine hydrochloride crystals |
| 03/24/1993 | EP0532703A1 Process for preparing microemulsion |
| 03/24/1993 | EP0532638A1 Branched polyanhydrides |
| 03/24/1993 | EP0532546A1 A pharmaceutical preparation containing n-glycofurols and n-ethylene glycols |
| 03/24/1993 | EP0312612B1 Nutritive emulsion |
| 03/24/1993 | CN1070108A Prescription and preparing process for finger or toe nail tinea paster |
| 03/24/1993 | CN1070107A Process for preparing Kouqiangning chewing gum (for curing oral diseases) |
| 03/24/1993 | CA2078712A1 Composition comprising amino acids for the prevention of hypoxic damage and a process for its preparation |
| 03/23/1993 | US5196453 Antitumor, immunosuppressive |
| 03/23/1993 | US5196436 Dextromethorphan antitussive compositions |
| 03/23/1993 | US5196417 Piroxicam-containing pharmaceutical composition for topical use |
| 03/23/1993 | US5196405 Compositions and methods of treating hemorrhoids and wounds |
| 03/23/1993 | US5196203 Treating cardiotonic, diuretic or respiratory conditions |
| 03/23/1993 | US5196202 Sustained release dosage form |
| 03/23/1993 | US5196201 Biocompatible bone tissue substitute in aqueous monoglyceride mixture; crystal structure |
| 03/23/1993 | US5196199 Hydrophilic form of perfluoro compounds and method of manufacture |
| 03/23/1993 | US5196185 Collagen-based wound dressing and method for applying same |
| 03/23/1993 | US5196184 Spray of Nifedipin, glycerol-polyethyleneglycol oxystearate, benzyl alcohol, ethanol, propellant |
| 03/23/1993 | US5196183 Fatty acid cores encapsulated with human serum albumin |
| 03/23/1993 | US5196002 Implantable drug delivery system with piston acutation |
| 03/23/1993 | CA1314760C Flavor and sweetness enhancement delivery systems and method of preparation |
| 03/21/1993 | CA2078579A1 Medicaments for treating gastrointestinal disorders |
| 03/20/1993 | CA2078606A1 Dihydropyridine derivatives useful in antitumor therapy |
| 03/18/1993 | WO1993005162A1 Method for delivering nucleic acids into cells |
| 03/18/1993 | WO1993005129A1 Emulsions of polar oils in water |
| 03/18/1993 | WO1993005096A1 Fatty acid terminated polyanhydrides |
| 03/18/1993 | WO1993004691A1 Compositions and methods for treating wounds |
| 03/18/1993 | WO1993004678A1 Antimicrobial preservation of platelets and blood factors |
| 03/18/1993 | WO1993004677A1 Anti-inflammatory analgesic plaster |
| 03/18/1993 | WO1993004676A1 High content ibuprofen agglomerates and process to prepare them |
| 03/18/1993 | WO1993004674A1 Softgel manufacturing process |
| 03/18/1993 | WO1993004673A1 Liposomal delivery system with photoactivatable triggered release |
| 03/18/1993 | WO1993004672A1 Method for enhancing the immune system in a host employing liposome-encapsulated polypeptides |
| 03/18/1993 | WO1993004671A1 Medicinal aerosol formulations |
| 03/18/1993 | WO1993004670A1 Dry gel composition |
| 03/18/1993 | DE4130843A1 Drug dosage form having variable and controlled drug release - includes drug reservoir under electrochemically generated gas pressure |
| 03/18/1993 | DE4125871A1 Dermatological preparations contg. tocopherol and isoprenoid lipid - synergise antibiotics, corticoid(s) and chemotherapeutics in treatment of eczema, allergy and esp. acne |
| 03/18/1993 | CA2119787A1 Softgel manufacturing process |
| 03/18/1993 | CA2116862A1 Medicinal aerosol formulations |
| 03/18/1993 | CA2116676A1 Method for delivering nucleic acids into cells |
| 03/18/1993 | CA2116549A1 Compositions and methods for treating wounds |
| 03/17/1993 | EP0532119A1 Composition comprising collagen fibre |
| 03/17/1993 | EP0531964A1 Divisible tablet |
| 03/17/1993 | EP0531938A1 Acrylic gel material and gel-based medical preparation for percutaneous absorption employing the same |
| 03/17/1993 | EP0531845A1 Pharmaceutical composition comprising a special crystall modification of 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarbonylic acid-(-2-methoxyethyl)-isopropyl ester |
| 03/17/1993 | EP0531611A1 Controlled release matrix for pharmaceuticals |
| 03/17/1993 | EP0531539A1 Lyophilized monoclonal antibody preparation |
| 03/17/1993 | EP0531529A1 Process for preparing aqueous suspension |
| 03/17/1993 | EP0531524A1 Sustained release suppository |
| 03/17/1993 | EP0516685A4 Artificial tears |
| 03/17/1993 | EP0435913B1 Effervescent tablet |
| 03/17/1993 | EP0425505B1 Transdermal antisecretory agents for gastrointestinal disease |
| 03/17/1993 | EP0250542B1 Transdermal delivery system |
| 03/17/1993 | CN1069887A Anti-common cold scent spray agent and its making method |
| 03/17/1993 | CN1069884A Preparation for medical pig skin by biological dressing radiation |
| 03/17/1993 | CN1069881A Process for antivirus powder without sugar |
| 03/17/1993 | CA2078088A1 Microcapsules made of isocyanates with groups containing polyethylene oxide |
| 03/16/1993 | US5194670 Storage stability |
| 03/16/1993 | US5194654 Viricides for retroviral infections such as aids |
| 03/16/1993 | US5194581 Biodegradable poly(phosphoesters) |
| 03/16/1993 | US5194464 Enteric film and preparatoin thereof |
| 03/16/1993 | US5194266 Amphotericin B/cholesterol sulfate composition and method |
| 03/16/1993 | US5194263 Particulate materials, their production and use |
| 03/16/1993 | US5194262 Encapsulated antiperspirant salts and deodorant/antiperspirants |
| 03/16/1993 | US5194259 Plant extracts |
| 03/16/1993 | US5194257 Kit and method for administration of bacillus calmette-guerin for the treatment of superficial bladder tumors |
| 03/16/1993 | US5194188 Mixing an amphiphilic compound and an active compound |
| 03/16/1993 | US5194003 Removable device for delivering beneficial agents orally |
| 03/16/1993 | CA1314485C Pharmaceutical composition for piperidinoalkanol-decongestant combination |
| 03/16/1993 | CA1314482C Intravaginal devices |
| 03/16/1993 | CA1314481C Liposomal preparation and antibiotic |
| 03/16/1993 | CA1314480C Mouldings made from pellets |
| 03/16/1993 | CA1314479C Oral drug delivery formulation and method for preparing same |
| 03/14/1993 | CA2095617A1 Composition providing a lasting cosmetic and/or pharmaceutical treatment of the upper epidermal layers by topical application on the skin |
| 03/11/1993 | DE4129998A1 Square shaped, cylindrically shaped consumable bar - contains relatively large amt. of medically effective plant material opt. covered by good tasting material e.g. chocolate |
| 03/10/1993 | EP0531091A1 Biodegradable copolyester of 4-hydroxy proline and pharmaceutical composition containing the same |
| 03/10/1993 | EP0531078A1 (R)-3-Methoxy-4- 1-methyl-5-(2-methyl-4,4,4-trifluorobutylcarbamoyl)indol-3-ylmethyl -N-(2-methylsulphonyl)benzamide in crystalline form |
| 03/10/1993 | EP0531005A2 Micro-emulsions |
| 03/10/1993 | EP0530995A1 Lozenges |
| 03/10/1993 | EP0530833A1 Process to prepare hard gelatine capsules containing chinese herbal extracts |
| 03/10/1993 | EP0524987A4 Eriodictyon drug delivery systems |
| 03/10/1993 | EP0455648B1 Dosage form for administering calcium antagonist |
| 03/10/1993 | EP0417191B1 Formulation for antibody reagents |
| 03/10/1993 | EP0329766B1 Sweet emulsion for chewing gum |
| 03/10/1993 | EP0312581B1 Pharmaceutical sustained release matrix and process |
| 03/10/1993 | CN1069659A Chinese medicine towel for curing urinary incontinence and its making method |